|
|
||||||||
AJP - Gastrointestinal and Liver Physiology, Vol 269, Issue 3 328-G334, Copyright © 1995 by American Physiological Society
ARTICLES |
T. Okumura, I. L. Taylor and T. N. Pappas
Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
Thyrotropin-releasing hormone (TRH) stimulates pancreatic exocrine secretion through the vagus nerve when injected into rat cerebrospinal fluid. However, little is known about the exact site of action of TRH in the brain to stimulate pancreatic secretion. Recent neuroimmunochemical and neurophysiological studies suggest that TRH could be a neurotransmitter in the dorsal vagal complex, which sends fibers to the pancreas through the vagus nerve. We therefore hypothesized that TRH may act centrally in the dorsal vagal complex to stimulate pancreatic exocrine secretion. To address this question, a TRH analogue, [1-methyl-(S)-4,5-dihydroorotyl]-L-histidyl-L-prolinamide- NH2, was microinjected into the dorsal vagal complex, and basal pancreatic fluid flow and protein secretion were measured in urethan-anesthetized rats. Microinjection of TRH analogue (0.2-2 ng/site) into the dorsal vagal complex significantly stimulated pancreatic flow and protein output in a dose-dependent manner. As a control, microinjection of the TRH analogue into the brain stem outside the vagal complex failed to stimulate pancreatic secretion. Either bilateral subdiaphragmatic vagotomy or atropine abolished the ability of the TRH analogue to stimulate pancreatic secretion. Our data suggest that TRH acts in the dorsal vagal complex to stimulate pancreatic secretion through vagus-dependent and cholinergic pathways. The dorsal vagal complex may play an important role as a central site for control of the exocrine pancreas.
This article has been cited by other articles:
![]() |
Z. Liao, Z.-S. Li, Y. Lu, and W.-Z. Wang Microinjection of exogenous somatostatin in the dorsal vagal complex inhibits pancreatic secretion via somatostatin receptor-2 in rats Am J Physiol Gastrointest Liver Physiol, March 1, 2007; 292(3): G746 - G752. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Martinez, M. D. Barrachina, G. Ohning, and Y. Tache Cephalic phase of acid secretion involves activation of medullary TRH receptor subtype 1 in rats Am J Physiol Gastrointest Liver Physiol, December 1, 2002; 283(6): G1310 - G1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Deng, D. R. Guarita, M. R. A. Pedroso, C. Kreiss, P. G. Wood, A. F. Sved, and D. C. Whitcomb PYY inhibits CCK-stimulated pancreatic secretion through the area postrema in unanesthetized rats Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R645 - R653. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Masuda, S. Kanai, and K. Miyasaka Inhibitory effect of central dopamine on basal pancreatic secretion in conscious rats Am J Physiol Gastrointest Liver Physiol, January 1, 1998; 274(1): G29 - G34. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Fragner, O. Presset, N. Bernad, J. Martinez, C. Roze, and S. Aratan-Spire A new biological contribution of cyclo(His-Pro) to the peripheral inhibition of pancreatic secretion Am J Physiol Endocrinol Metab, December 1, 1997; 273(6): E1127 - E1132. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |